Chemotherapy can affect the ovaries, periods and fertility, and for younger women this is one of the most pressing questions after diagnosis. The single most important fact is this: any steps to protect your fertility are most effective before chemotherapy begins, so the conversation needs to happen early. At CION, a woman-led team raises fertility up front, explains how chemo may affect your ovaries, and — if you wish — connects you quickly with fertility specialists for fertility preservation before treatment starts.
A woman is born with all the eggs she will ever have, stored in the ovaries — her "ovarian reserve". Chemotherapy works by attacking fast-dividing cells, and some chemotherapy drugs can also damage the eggs and the ovarian tissue. This can reduce the ovarian reserve, stop or disrupt periods, and in some women bring on early or permanent menopause. The effect is not the same for everyone — it depends on your age, the specific drugs and dose used, and how much reserve you had to begin with.
This matters most for younger women who may want children in the future, and it is a particular concern in India, where breast cancer is often diagnosed a decade earlier than in the West and many patients are in their 30s and 40s. The encouraging message is that fertility can often be protected — but only if the conversation happens before treatment starts. That is why we raise it early for every younger woman, including those with breast cancer in young women.
Some chemotherapy drugs damage eggs and ovarian tissue, reducing the reserve and sometimes bringing on early menopause — but the degree varies widely between women.
Younger women have more reserve and are more likely to keep or regain fertility; women closer to natural menopause are more likely to enter it permanently.
Steps to protect fertility work best before chemotherapy begins. Raising it early — not after — is the single most important thing you can do.
International guidelines recommend that every woman of childbearing age facing chemotherapy should be told about possible effects on fertility and offered referral for fertility preservation — before treatment begins. Yet many women are never asked. Because egg, embryo and ovarian-tissue freezing are far more effective done up front, raising the question early can make all the difference. If having children may matter to you one day, ask before you start chemo. Source: ASCO Fertility Preservation guidance; NCCN.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
There is no single answer to "will chemo make me infertile?" — the risk sits on a spectrum and depends on several factors together. Understanding them helps you and your oncologist judge your individual situation and decide whether to take fertility-preservation steps before starting.
The most important factor. Women in their 20s and early 30s usually have more ovarian reserve and a better chance of periods and fertility returning than women in their late 30s and 40s.
Some chemotherapy regimens are harder on the ovaries than others, and a higher total (cumulative) dose carries more risk. Your oncologist can explain where your planned regimen sits.
If your ovarian reserve was already lower before treatment, there is less buffer against chemotherapy's effect. A simple blood test and scan can estimate your reserve.
For hormone-positive cancer, years of hormone therapy usually follow chemo, during which pregnancy is avoided. This delay matters because fertility naturally declines with age while you wait.
If having children in the future matters to you, there are established ways to protect that chance — and they are most effective when done before chemotherapy starts. A quick referral to a fertility specialist, arranged alongside your cancer plan, lets you understand the options without delaying treatment unduly. Our dedicated fertility preservation page goes into each in depth.
Eggs are collected after a short course of hormone stimulation, then frozen for future use. A good option if you do not have a partner or prefer not to create embryos now.
Eggs are collected and fertilised with a partner's or donor sperm, and the resulting embryos are frozen. This is a well-established route with strong success rates.
A piece of ovarian tissue is removed and frozen for possible later re-implantation. It can be done quickly and is an option when there is little time before chemo.
Injections that temporarily switch off the ovaries during chemotherapy may offer some protection for the ovaries. It is sometimes used alongside, not instead of, freezing.
Many women notice their periods change during chemotherapy — becoming irregular, lighter, or stopping altogether. This is expected and does not mean anything is wrong. What it means for your long-term fertility is a separate question, and the two are easy to confuse. Here is what to expect, and why periods alone are not a reliable guide to fertility.
It is common for periods to become irregular or stop during chemotherapy as the ovaries are temporarily affected. This is expected and not a sign that something has gone wrong.
In younger women especially, periods often return in the months after chemotherapy ends, though they may be irregular at first. The closer you are to natural menopause, the less likely they are to return.
Returning periods are reassuring but do not guarantee you can conceive — ovarian reserve may still be reduced. Conversely, absent periods do not always mean permanent infertility.
Even with irregular or absent periods, pregnancy should be avoided during chemotherapy because the drugs can harm a developing baby. Non-hormonal contraception is usually advised — discuss the right method with your team.
Fertility is easy to overlook in the rush to start cancer treatment — but for a young woman it can shape her whole future. CION is a woman-headed, tumour-board-led organisation that raises fertility before treatment, not after, so you never lose the window to protect it.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Woman-led, tumour-board-reviewed care that raises fertility before treatment — across 35+ centres in Telangana & AP. Call 1800-202-8726.
Many women understandably wonder whether pregnancy is even possible — or safe — after breast cancer. The reassuring news is that many women do go on to have healthy pregnancies after treatment, and current evidence does not show that pregnancy increases the risk of the cancer returning. The key is timing and planning: the right gap before trying, and a conversation with your oncologist first. Our dedicated pregnancy after breast cancer page covers this in depth.
At CION, we plan this with you honestly, balancing your wish to have a baby with the treatment that keeps you well.
Because the window to protect fertility is before treatment, it helps to come to your consultation ready to ask. These questions make sure fertility is on the table from the start, not raised too late. A good team will welcome them — at CION we usually raise them first.
The most important thing is always treating the cancer well — but for younger women, that does not have to mean giving up on the dream of a family. With careful planning, fertility preservation can usually be done without compromising your cancer outcome. The two goals are not opposites; they simply need to be coordinated by an experienced team that looks at the whole picture. CION's outcomes for breast cancer run meaningfully ahead of the national average, and protecting fertility is built into that whole-person care.
We will be honest about what is possible for your situation, never overpromising — but we will make sure fertility is considered, not forgotten.
CION breast cancer 1-year survival: 96.9% vs national average 85.4% (+11.5%). *1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP).
You should not have to choose between treating your cancer and your hope of a family — not before you have all the facts. CION offers a clear, woman-led pathway that puts fertility on the table from day one, with your first consultation free.
A specialist reviews your diagnosis and your age, explains how your treatment may affect fertility, and asks — early — whether having children matters to you.
If you wish to preserve fertility, we arrange a prompt referral to fertility specialists for egg, embryo or tissue freezing — coordinated so it does not unduly delay treatment.
Your oncologists plan treatment together, balancing effective cancer control with your fertility wishes, your stage and your hormone status.
We guide you on periods, contraception during chemo, and — when the time is right — planning pregnancy after treatment, with counselling throughout.
Hear from patients treated at CION — diagnosis, treatment path, and where they are today.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Not necessarily. Chemotherapy can affect the ovaries and reduce ovarian reserve, but the impact varies a lot between women. The most important factor is your age — women in their 20s and early 30s are more likely to keep or regain fertility than women in their late 30s and 40s. The specific drugs, the total dose, and how much ovarian reserve you started with also matter. Some women remain fertile after treatment, some have temporary changes, and some enter early menopause. Because the effect cannot be predicted with certainty, the safest approach is to discuss fertility preservation before chemotherapy begins, when it is most effective.
Because chemotherapy can damage eggs and ovarian tissue, the time to protect them is before that damage occurs. Egg freezing, embryo freezing and ovarian tissue freezing are all far more effective when done up front, while your ovarian reserve is intact. International guidelines recommend that every woman of childbearing age facing chemotherapy be told about possible fertility effects and offered a referral before treatment starts. Preservation can usually be coordinated to fit your timeline without unduly delaying cancer treatment. This is why we raise fertility early at CION — once chemotherapy has started, the most effective options may no longer be available.
Often, yes. It is common for periods to become irregular, lighter or stop altogether during chemotherapy because the ovaries are temporarily affected. This is expected and does not mean anything has gone wrong. In younger women, periods frequently return in the months after chemotherapy ends, although they may be irregular at first. The closer you are to natural menopause, the less likely they are to return. Importantly, even if your periods stop or become irregular, you should still avoid pregnancy during chemotherapy and use contraception, because the drugs can harm a developing baby. Discuss the right contraceptive method with your team.
Not always. Returning periods are reassuring and suggest the ovaries are working again, but they do not guarantee that you can conceive — your ovarian reserve may still be reduced compared with before treatment. The reverse is also true: absent periods do not always mean permanent infertility. Because periods alone are not a reliable guide to fertility, a fertility specialist can assess your ovarian reserve with a simple blood test and scan if you are planning a pregnancy. The most reliable insurance, if children matter to you, is to have preserved eggs or embryos before treatment, when the chance of success is highest.
Many women do go on to have healthy pregnancies after breast cancer, whether naturally or using eggs or embryos frozen beforehand. Reassuringly, current evidence does not show that becoming pregnant after breast cancer increases the risk of the cancer returning. The keys are timing and planning: most teams advise waiting a period after treatment before trying, and for hormone-receptor-positive cancer this is balanced against the years of hormone therapy that usually follow. Always plan with your oncologist first — they will advise on the right gap, any pause in hormone therapy, and the safest path. Our pregnancy after breast cancer page explains this in more depth.
There are several established options. Egg freezing collects and freezes your eggs after a short hormone-stimulation course — a good choice if you do not have a partner. Embryo freezing fertilises the eggs with partner or donor sperm and freezes the embryos, a well-established route with strong success rates. Ovarian tissue freezing removes and freezes a piece of ovarian tissue for possible later use, and can be done quickly when time is short. Ovarian suppression with injections during chemotherapy may offer some protection for the ovaries and is sometimes used alongside freezing. Which is right depends on your age, time available, partner status and preferences. Our fertility preservation page covers each in detail.
The single most important step is to raise fertility with your oncologist before chemotherapy starts, even if you are unsure whether you want children. Ask how likely your treatment is to affect your fertility, whether you can see a fertility specialist quickly, and whether preservation would delay your cancer treatment. Because the most effective options must be done before chemo, acting early keeps all your choices open. At CION we usually raise this first for younger women, including those diagnosed with breast cancer in young women, and can arrange a prompt fertility referral coordinated with your cancer plan. You can book a free consultation on 1800-202-8726 or through the form on this page.
Yes. CION offers a free first consultation for all cancer patients, including younger women who want to understand how chemotherapy may affect fertility and what they can do about it. It is a full 45-minute consultation — a specialist reviews your diagnosis and age, explains the likely fertility impact of your planned treatment, asks early whether children matter to you, and — if you wish — arranges a prompt referral for fertility preservation coordinated with your cancer plan. There are no rushed decisions and no unnecessary tests, and CION offers up to 50% discounts on diagnostics. You can book on 1800-202-8726 or request a callback through the form on this page.
Browse our complete guide to breast cancer — types, symptoms, tests and treatments. Tap any topic to read more.